Metastatic lymph node ratio as an independent prognostic factor in stage III gastric cancer after D2 nodal dissection.
Jieer Ying(Chinese Academy of Medical Sciences & Peking Union Medical College), Qi Xu(China Jiliang University), Yigong Zhang(Second Affiliated Hospital of Zhejiang University), Cong Li(Zhejiang Cancer Hospital)
Cited by 0
Related Papers
Hepatogastroenterology
|Hepatogastroenterology|2012|1.3k
Donafenib Versus Sorafenib in First-Line Treatment of Unresectable or Metastatic Hepatocellular Carcinoma: A Randomized, Open-Label, Parallel-Controlled Phase II-III Trial
|Journal of Clinical Oncology|2021|417
The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2023
|癌症：英文版|2023|412